Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Optic nerve regeneration pathway identified by BLSI collaborators

Jan. 25, 2000

Glaxo Wellcome and NeuroSearch to develop NS-2389 for treatment of depression

Jan. 24, 2000

StemCells reports first direct isolation of human brain stem cells

Jan. 24, 2000

Selective GABA-A ligands synthesized at MS&D for use particularly as nonsedating anxiolytics

Jan. 24, 2000

Recently issued patent covers Neurogens new selective dopamine D4 ligands

Jan. 24, 2000

Novel anticonvulsants in development at SmithKline Beecham

Jan. 24, 2000

NAALADase inhibition as an effective and safe therapeutic strategy for stroke

Jan. 21, 2000

Compounds active at human 5-HT1A receptors designed at AHP

Jan. 21, 2000

Positive results for memantine in phase IIb trial for treatment of neuropathy

Jan. 21, 2000

Arena granted SBIR award for atypical antipsychotics

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.